Squarepoint
NUVB icon

Squarepoint’s Nuvation Bio NUVB Stock Holding History

Squarepoint’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$536K Buy
+124,944
New +$696K ﹤0.01% 3284
2025
Q4 		– Sell
-302,863
Closed -$1.12M – 4693
2025
Q3 		$1.12M Buy
+302,863
New +$825K ﹤0.01% 2596
2025
Q2 		– Sell
-90,730
Closed -$160K – 4875
2025
Q1 		$160K Sell
90,730
-18,281
-17% -$41.6K ﹤0.01% 4092
2024
Q4 		$290K Sell
109,011
-121,986
-53% -$314K ﹤0.01% 4174
2024
Q3 		$529K Buy
+230,997
New +$704K ﹤0.01% 3048
2024
Q2 		– Sell
-21,138
Closed -$76.9K – 4469
2024
Q1 		$76.9K Sell
21,138
-153,139
-88% -$294K ﹤0.01% 3832
2023
Q4 		$263K Sell
174,277
-29,829
-15% -$38.4K ﹤0.01% 3440
2023
Q3 		$274K Buy
204,106
+148,992
+270% +$248K ﹤0.01% 3230
2023
Q2 		$99.2K Sell
55,114
-19,071
-26% -$32.4K ﹤0.01% 3360
2023
Q1 		$123K Buy
74,185
+49,713
+203% +$101K ﹤0.01% 2936
2022
Q4 		$47K Sell
24,472
-48,774
-67% -$98.7K ﹤0.01% 3061
2022
Q3 		$164K Sell
73,246
-18,605
-20% -$53.1K ﹤0.01% 2727
2022
Q2 		$298K Buy
+91,851
New +$401K ﹤0.01% 2292
2021
Q2 		– Sell
-10,904
Closed -$114K – 3555
2021
Q1 		$114K Buy
+10,904
New +$122K ﹤0.01% 2868

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Squarepoint's NUVB Position: Q1 2026 in Review

Squarepoint opened a new position in Nuvation Bio (NUVB) in Q1 2026: 124,944 shares worth $536K. The stake represents ﹤0.01% of the portfolio and ranks #3284 among its holdings. This is a return to the name: Squarepoint previously reported a position in NUVB as recently as Q3 2025.

Squarepoint first reported a position in NUVB in Q1 2021 and has held it in 14 quarters since. The position peaked at $1.12M in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Squarepoint held 124,944 shares of Nuvation Bio worth $536K as of Q1 2026.
  • Nuvation Bio was a new Squarepoint position in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3284 holding.
  • Squarepoint first reported a position in Nuvation Bio in Q1 2021 and has held it in 14 quarters since.
  • Squarepoint's Nuvation Bio position peaked at $1.12M in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.